HEMI (L)-TARTRATE FORMS OF 3-({5-CHLORO-1-[3-(METHYLSULFONYL)PROPYL]-1H-INDOL-2-YL}METHYL)-1-(2,2,2-TRIFLUOROETHYL)-1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | Patent Publication Number 20210387984
US 20210387984 A1Publication DateDec 16, 2021
Original Assignee
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsJasmine BOGAERTS
Eszter TIEGER
Jan Jos L. BEVERNAGE
Kristof Leonard KIMPE
Eszter TIEGER
Jan Jos L. BEVERNAGE
Kristof Leonard KIMPE
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.